AI-generated summary
The authors report a consensus process in which an international panel of 21 experts drafted recommendations informed by a systematic literature search, then refined them through Delphi surveys and consensus meetings. They report that PBM is considered safe for adults and effective for several listed conditions, including peripheral neuropathy and androgenic alopecia. The abstract does not give details of the underlying studies' quality or effect sizes.
- Who or what was studied
- adult patients with conditions such as peripheral neuropathy, androgenic alopecia, wound and decubitus ulcers, diabetic foot ulcer pain, and acute radiation dermatitis
- Limits stated in the abstract
- The abstract does not report the number of studies included or the strength of the evidence behind each conclusion, and it describes a consensus of experts rather than a quantitative pooled analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.